Prognostic Significance of the Loss of Heterozygosity of
KRAS
LOH
NSCLC
copy number aberration
prognostic marker
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
10
02
2022
accepted:
31
03
2022
entrez:
16
5
2022
pubmed:
17
5
2022
medline:
17
5
2022
Statut:
epublish
Résumé
Lung cancer is a common disease with a poor prognosis. Genomic alterations involving the
Identifiants
pubmed: 35574381
doi: 10.3389/fonc.2022.873532
pmc: PMC9098994
doi:
Types de publication
Journal Article
Langues
eng
Pagination
873532Informations de copyright
Copyright © 2022 Khadse, Haakensen, Silwal-Pandit, Hamfjord, Micke, Botling, Brustugun, Lingjærde, Helland and Kure.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Diagn Mol Pathol. 2011 Sep;20(3):158-65
pubmed: 21817902
Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16910-5
pubmed: 20837533
Eur J Cancer. 2012 Jun;48(9):1299-311
pubmed: 22464348
Radiology. 2017 Jan;282(1):251-258
pubmed: 27440441
PLoS One. 2013 Oct 24;8(10):e78614
pubmed: 24205279
Nat Genet. 2013 Oct;45(10):1127-33
pubmed: 24071851
BMC Cancer. 2021 Oct 9;21(1):1089
pubmed: 34625038
Eur Respir J. 2012 Jul;40(1):177-84
pubmed: 22267755
Mol Oncol. 2016 Feb;10(2):330-43
pubmed: 26601720
Int J Cancer. 2013 May 1;132(9):2020-31
pubmed: 23023297
J Clin Oncol. 2007 Nov 20;25(33):5240-7
pubmed: 18024870
Br J Cancer. 2010 Mar 16;102(6):1024-31
pubmed: 20197771
Lung Cancer. 2019 Apr;130:50-58
pubmed: 30885352
Nature. 2013 Jul 11;499(7457):214-218
pubmed: 23770567
Nat Commun. 2020 Feb 5;11(1):715
pubmed: 32024838
Elife. 2015 Jun 05;4:e06907
pubmed: 26047463
Lung Cancer. 2016 Sep;99:102-10
pubmed: 27565922
PLoS One. 2017 Nov 7;12(11):e0187246
pubmed: 29112949
J Clin Oncol. 2013 Jun 10;31(17):2173-81
pubmed: 23630215
PLoS One. 2012;7(2):e31906
pubmed: 22363766
N Engl J Med. 2020 Sep 24;383(13):1207-1217
pubmed: 32955176
Cell Adh Migr. 2010 Jan-Mar;4(1):100-6
pubmed: 20139701
Nature. 2014 Jul 31;511(7511):543-50
pubmed: 25079552
Genes Dev. 2005 Mar 15;19(6):643-64
pubmed: 15769940
Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):15823-15829
pubmed: 31332011
Cancer Sci. 2004 Mar;95(3):197-204
pubmed: 15016317
Cancer Lett. 2017 Jan 1;384:86-93
pubmed: 27725226
Mol Cancer. 2006 Jun 19;5:25
pubmed: 16784539
Clin Cancer Res. 2008 Sep 15;14(18):5731-4
pubmed: 18794081
PLoS One. 2012;7(5):e36530
pubmed: 22590557
Nature. 2007 Dec 6;450(7171):893-8
pubmed: 17982442
Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):990-5
pubmed: 26747605
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Semin Cell Dev Biol. 2016 Oct;58:60-9
pubmed: 27422332
Oncogene. 2013 Aug 22;32(34):4028-33
pubmed: 22945650
Lung Cancer. 2018 Aug;122:138-145
pubmed: 30032822
Respir Med. 2005 Mar;99(3):308-12
pubmed: 15733506
J Thorac Oncol. 2011 Nov;6(11):1833-40
pubmed: 22011649